Capital Advisors Wealth Management LLC Boosts Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Capital Advisors Wealth Management LLC lifted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 22.5% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 594 shares of the healthcare conglomerate’s stock after purchasing an additional 109 shares during the quarter. Capital Advisors Wealth Management LLC’s holdings in UnitedHealth Group were worth $301,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently made changes to their positions in UNH. Kathleen S. Wright Associates Inc. purchased a new stake in shares of UnitedHealth Group during the third quarter worth $27,000. Global Wealth Strategies & Associates increased its holdings in UnitedHealth Group by 152.4% during the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after purchasing an additional 32 shares during the period. West Financial Advisors LLC purchased a new position in shares of UnitedHealth Group in the 3rd quarter valued at about $32,000. Quarry LP increased its stake in shares of UnitedHealth Group by 132.1% during the second quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock worth $33,000 after buying an additional 37 shares during the period. Finally, RPg Family Wealth Advisory LLC purchased a new position in UnitedHealth Group in the third quarter worth approximately $37,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH opened at $511.02 on Friday. The stock has a market capitalization of $470.28 billion, a P/E ratio of 33.29, a P/E/G ratio of 1.42 and a beta of 0.62. The company’s fifty day moving average is $553.38 and its two-hundred day moving average is $562.98. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same quarter in the previous year, the company earned $5.83 EPS. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were issued a $2.10 dividend. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.64%. UnitedHealth Group’s dividend payout ratio is presently 54.72%.

Wall Street Analysts Forecast Growth

UNH has been the topic of a number of analyst reports. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective on the stock in a report on Friday, January 10th. Oppenheimer upped their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Morgan Stanley decreased their target price on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. Bank of America cut their price objective on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. Finally, Royal Bank of Canada cut their price target on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 16th. Two investment analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and three have given a strong buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Buy” and a consensus price target of $626.79.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.